2Sterzel RB, Schulze - Lohoff E, Marx M. Cytokines and mesangial eclls. Kidney Int, 1993, 43(39) :26- 32.
3Yasuhiro H, Masayuki I, Eiji H, et al. Role of interleukin - 6 in the progression of mesangial proliferative glomernlonephritis. Kindey Int, 1993, 43( 39 ) : 71-75.
4Ruef C, Budde K, Lacy J, et al. Interleukin - 6 in an autocrine growth factor for mesangial cells, Kidney Int, 1993,43:544-560.
5Ruff C, Budde k, Lacy J, et al. IL- 6 is an autocrine growth factor for mesangial cells. Kidney Internatioal, 1990, 38..249-254.
6Fukatsu A, Matsuo S, Tamai H, et al. Distribution of interleukin - 6 in normal and diseased human kidney. Kidney Int, 1991,65:61-65.
8Chae S H, Kim P S, Cho J Y, et al. Isolation and identification of inhibitory compounds on TNF-α production from Magnollae fargesii [J]. Arch Pharm Res, 1998, 21 (1): 67-69.
9Cho J Y, Kim A R, Yoo E S, et al. Immunomodulatory effect of arctigenin, a lignan compound on tumor necrosis factor-α and nitric oxide production, and lymphocyte proliferation [J]. J Pharm Pharmacol, 1999, 51 (11): 1267-1273.
10Cho M K, Park J W, Jang Y P, et al. Lipopolysaccharideinducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-κBα phosphorylation and of p65 nuclear translocation in macrophages [J]. Int Immunopharmacol, 2002, 67 (6) : 1738-1745.
